Skip to main content
OpenTrials
Completed

NCT Number: NCT06635265

A Study to Determine the Flow Changes And/or AHI Reduction When Stimulating Two Targets (neural And/or Muscular) for the Treatment of Obstructive Sleep Apnea in Adult Subjects

This Proof-of-Concept study will collect acute and sub-acute flow and/or AHI data following the placement of lead arrays under direct vision. The acute placement and data collection will be collected following the completion of the pre-scheduled neck dissection surgery. The sub-acute data will be collected in a sleep lab during a polysomnography (PSG). Both data collections will be done when stimulating (using an external pulse generator) the hypoglossal nerve or Genioglossus muscle (GG) and a second neural target (Ansa Cervicalis - AC) or the strap muscles (sternohyoid and sternothyroid) with a set of Off-the-Shelf (OTS) electrode arrays.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Perth Head and Neck Surgery

Perth, Western Australia, 6009, Australia

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

A patient must meet all of the following inclusion criteria to be eligible for inclusion in this study:

  • Age above 18 years not under guardianship, under curatorship or under judicial protection.
  • Body Mass Index (BMI) < 38 kg/m2.
  • Subject must be eligible for neck dissection surgery.
  • Written informed consent obtained from the patient prior to performing any study specific procedure.
  • Willing and capable to comply with all study requirements, including specific lifestyle considerations, evaluation procedures and questionnaires for the whole duration of the trial.

Exclusion criteria

Patients meeting any of the following criteria will be excluded from participation in this study:

  • Major anatomical or functional abnormalities that would impair the ability of the electrode arrays to be positioned.
  • Significant comorbidities that contraindicate surgery or general anesthesia.
  • Significant tongue weakness.
  • Aerodigestive tract tumor or reconstructive surgery performed at the same time as neck dissection.
  • Any other chronic medical illness or condition that contraindicates a surgical procedure or general anesthesia in the judgment of the investigator.
  • Prior surgery or treatments that could compromise the placement and effectiveness of the electrode array systems:
  • Airway cancer surgery or radiation, or
  • Mandible or maxilla surgery in the previous 3 years (not counting dental treatments).
  • Other upper airway surgery to remove obstructions related to OSA in the previous 3 months (e.g., uvulopalatopharyngoplasty (UPPP), tonsillectomy, nasal airway surgery).
  • Prior hypoglossal nerve stimulation device implantation.
  • Currently pregnant or breastfeeding during the study period.
  • Concomitant oral or pharyngeal surgery.

Treatment and study plan

Target Stimulation (HGN, AC, GG, Strap muscles)

Device

Simulation of a combination of: HGN, AC, GG or strap muscles

Primary outcomes

  1. Impacts on acute airway opening

    Time frame: Day 0 to 3

    Demonstration of acute airway opening as visually observed under nasoendoscopy when stimulating the HGN or GG and a second target (neural or direct muscle stimulation).

  2. Impacts on airflow during a acute assessment

    Time frame: Day 0 to 3

    Acute increase in airflow when stimulating the HGN or GG and a second target (neural or direct muscle stimulation), measured by changes in amplitude (mA) during target stimulation.

Secondary outcomes

  1. Impacts on airway opening during a sub-acute assessment

    Time frame: Day 0 to 3

    Demonstration of sub-acute flow increase and/or AHI reduction when stimulating two targets simultaneously during natural sleep as measured with polysomnography (PSG), measured by polysomnography.

Sponsors and collaborators

Lead sponsor

Invicta Medical Inc.

Industry

Collaborators

  • Hollywood Private Hospital

Registry information

Official study title

Single Center Proof-of-Concept Study to Determine the Flow Changes And/or AHI Reduction When Stimulating Two Targets (neural And/or Muscular) for the Treatment of Obstructive Sleep Apnea in Adult Subjects

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Oct 10, 2024
Registry last updated
Oct 10, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.